Developing the 134Ce and 134La pair as companion positron emission tomography diagnostic isotopes for 225Ac and 227Th radiotherapeutics

TA Bailey, V Mocko, KM Shield, DD An, AC Akin… - Nature Chemistry, 2021 - nature.com
Developing targeted α-therapies has the potential to transform how diseases are treated. In
these interventions, targeting vectors are labelled with α-emitting radioisotopes that deliver …

New directions in nuclear data research for accelerator-based production of medical radionuclides

SM Qaim - Journal of Radioanalytical and Nuclear Chemistry, 2024 - Springer
Extensive nuclear data studies have been carried out over the last 30 years in the context of
accelerator-based production of radionuclides, especially at energies below 30 MeV, and …

Investigating high-energy proton-induced reactions on spherical nuclei: Implications for the preequilibrium exciton model

MB Fox, AS Voyles, JT Morrell, LA Bernstein, AM Lewis… - Physical Review C, 2021 - APS
Background: A number of accelerator-based isotope production facilities utilize 100-to 200-
MeV proton beams due to the high production rates enabled by high-intensity beam …

Excitation functions of alpha particle induced nuclear reactions on natBa up to 60 MeV

IA Khomenko, ES Kormazeva, VN Unezhev… - Nuclear Instruments and …, 2023 - Elsevier
The excitation functions of nuclear reactions nat Ba (α, xn) 132, 133m, 134, 135, 137m, g,
139, 141 Ce, nat Ba (α, x) 135, 140 La and nat Ba (α, x) 131, 133m, 135m Ba were …

[HTML][HTML] Extension of recommended cross section database for production of therapeutic isotopes

F Tárkányi, A Hermanne, AV Ignatyuk, F Ditrói… - … of Radioanalytical and …, 2024 - Springer
Radionuclide-based diagnostics and therapy require proper selection of production nuclear
reaction based on knowledge of the production excitation functions and the achievable …

Report of the Snowmass' 21 Workshop on High-Power Cyclotrons and FFAs

D Winklehner, A Adelmann, JR Alonso… - arXiv preprint arXiv …, 2022 - arxiv.org
This whitepaper summarizes and the state of the field of high-power cyclotrons and FFAs as
discussed by international experts during a three-day workshop of the same name. The …

Measurement of Proton-Induced Reactions on Lanthanum from 55--200 MeV by Stacked-Foil Activation

JT Morrell, EM O'Brien, M Skulski, AS Voyles… - arXiv preprint arXiv …, 2024 - arxiv.org
Cerium-134 is an isotope desired for applications as a chemical analogue to the promising
therapeutic radionuclide $^{225} $ Ac, for use in bio-distribution assays as an in vivo …

First Report of the Nuclear Data Subcommittee of the Nuclear Science Advisory Committee

Accurate, reliable nuclear data is essential for the success of Federal missions such as
nonproliferation, nuclear forensics, homeland security, national defense, space exploration …

High-power Fixed-Field Accelerators

D Winklehner, A Adelmann, JR Alonso… - Journal of …, 2023 - iopscience.iop.org
We report the state of the field of High-Power Fixed-Field Accelerators (with an emphasis on
cyclotrons) as discussed by international experts during a three-day workshop of the same …

Cerium-139 radionuclide production from proton-induced nuclear reaction on Lanthanum-139 target for diagnostic applications

FA Wibowo, I Kambali - AIP Conference Proceedings, 2024 - pubs.aip.org
As a monoenergetic gamma-ray emitter with a half-life of 137.63 days, Cerium-139 (Ce-139
or 139Ce) has been proposed as a diagnostic agent in nuclear medicine using Single …